The Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact On Outcome in Acute Myeloid Leukemia

被引：2
|
作者：
Chen, Xueyan
Xie, Hu [1 ]
Bohm, Carl
Wood, Brent L. [2 ]
Pagel, John M. [1 ]
Becker, Pamela S. [3 ]
Walter, Roland B. [1 ]
Sandhu, Ravinder K. [1 ]
Abkowitz, Janis L.
Appelbaum, Frederick R. [1 ]
Estey, Elihu H. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[3] Univ Washington, Div Hematol, Seattle, WA 98195 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1418.1418
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1418
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Multivariate analysis of prognostic impact of flow cytometrically determined minimal residual disease in patients with acute myeloid leukemia.
    Kern, W
    Voskova, D
    Schoch, C
    Schnittger, S
    Haferlach, T
    BLOOD, 2005, 106 (11) : 667A - 667A
  • [42] Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of Minimal Residual Disease in Acute Myeloid Leukemia
    Oran, Betul
    Singleton, Timothy
    Ramirez, Pablo A.
    Shanley, Ryan
    Brunstein, Claudio
    Ustun, Celalettin
    Warlick, Erica D.
    Weisdorf, Daniel J.
    BLOOD, 2011, 118 (21) : 887 - 887
  • [43] Determination of minimal residual disease in patients with acute myeloid leukemia by multiparameter flow cytometry: Prognostic impact at different checkpoints
    Kern, W
    Voskova, D
    Schoch, C
    Hiddemann, W
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (11) : 117A - 117A
  • [44] Impact of pretransplant minimal residual disease detection by flow cytometry in acute myeloid leukemia
    Perez, E.
    Lopez-Godino, O.
    Cabrero, M.
    Labrador, J.
    Alonso, S.
    Perez, J. J.
    Lopez-Corral, L.
    Vazquez, L.
    Gonzalez, M.
    Hernadez, J. M.
    Puig, N.
    Diez-Campelo, M.
    Martin, A.
    Mateos, M. V.
    Paiva, B.
    del Canizo, M. C.
    San Miguel, J.
    Caballero, M. D.
    Vidriales, M. B.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S238 - S239
  • [45] Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia
    Hirsch, Pierre
    Tang, Ruoping
    Abermil, Nassera
    Flandrin, Pascale
    Moatti, Hannah
    Favale, Fabrizia
    Suner, Ludovic
    Lorre, Florence
    Marzac, Christophe
    Fava, Fanny
    Mamez, Anne-Claire
    Lapusan, Simona
    Isnard, Francoise
    Mohty, Mohamad
    Legrand, Ollivier
    Douay, Luc
    Bilhou-Nabera, Chrystele
    Delhommeau, Francois
    HAEMATOLOGICA, 2017, 102 (07) : 1227 - 1237
  • [46] Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemia
    Zhang, Congxiao
    Gu, Runxia
    Wang, Huijun
    Zhou, Chunlin
    Li, Yan
    Liu, Yuntao
    Wei, Shuning
    Lin, Dong
    Liu, Kaiqi
    Fang, Qiuyun
    Gong, Xiaoyuan
    Gong, Benfa
    Qiu, Shaowei
    Zhang, Guangji
    Liu, Bingcheng
    Wang, Ying
    Mi, Yingchang
    Wei, Hui
    Wang, Jianxiang
    CANCER, 2025, 131 (01)
  • [47] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID-LEUKEMIA
    GERHARTZ, HH
    SCHMETZER, H
    LEUKEMIA, 1990, 4 (07) : 508 - 516
  • [48] Detection of minimal residual disease in acute myeloid leukemia.
    Baer M.R.
    Current Oncology Reports, 2002, 4 (5) : 398 - 402
  • [49] Molecular Minimal Residual Disease in Acute Myeloid Leukemia REPLY
    Lowenberg, Bob
    Valk, Peter J. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25): : 2443 - 2443
  • [50] Minimal Residual Disease in Acute Myeloid Leukemia: Prognostication and Pitfalls
    Stein, Eytan M.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (08) : 485 - +
12345